Insights

The global clinical research community watched closely for the release of ICH E6(R3) Good Clinical Practice (GCP), the long-awaited update to the foundational guideline from the International Council on Harmonization (ICH). On September 9, 2025, the U.S. Food and Drug Administration (FDA) posted the final version on its website and published it in the Federal Register. This signals that the guideline is officially available in the United States and provides a clear reference point for industry and regulators alike. 

Recognizing that successfully onboarding entrants into clinical research programs is only the beginning of the battle necessary for building a durable and engaged workforce, Merck and the Association of Clinical Research Professionals (ACRP) have collaborated on a bold approach to training and keeping some of the company’s newest and most promising talent on the path to long-term careers in clinical trials.

Alzheimer’s clinical development has moved from decades of disappointment toward cautious optimism. For nearly 20 years, most Phase III programs targeting amyloid ended in futility, leaving clinicians and caregivers disheartened.